Registered Owners
- View profile →
FERRON PAR PHARMACEUTICALS
Kota Bekasi, Jawa Barat, Indonesia
NPWP: 017134032431000
owner
Direktorat Registrasi ObatValid
BENDAMUSTINE HCL MONOHYDRATE
- BPOM Number
- GKL2134615944A1
- Approved
- 2 November 2025
- Expiry
- 1 November 2030
- Form
- SERBUK INJEKSI LIOFILISASI
About This Registration
BENDAMUSTINE HCL MONOHYDRATE is a BPOM-registered direktorat registrasi obat in Indonesia, registered under number GKL2134615944A1. Its current registration status is Valid, with the licence valid until 1 November 2030. The product is registered to FERRON PAR PHARMACEUTICALS and manufactured by FERRON PAR PHARMACEUTICALS - INDONESIA. BPOM first approved this registration in November 2025. All registration data is sourced directly from the official BPOM public database and updated daily.
Registration data updated by BPOM
This product's registration details were changed on 13 November 2025. This may reflect a status change, renewal, or correction by BPOM.
Registration Details
- Application
- newaero
- Packaging
- DUS, 1 VIAL @ 100 MG
- Department
- Direktorat Registrasi Obat
- Data Last Updated
- 13 November 2025
Retail Audit Service
Get detailed market intelligence for this product across Indonesian retail channels
Multiple cities available
Custom questionnaires
Professional shoppers
Detailed reporting
Starting from $50 per city
What's included in the audit service?
Stock availability and positioning verification
Price checking and competitor analysis
Display quality and promotional material assessment
Store condition and customer experience evaluation
Custom questions tailored to your research needs
Professional photographs and detailed reports
Manufacturing Sites
- View profile →
FERRON PAR PHARMACEUTICALS - INDONESIA
KAB. BEKASI
primary
Ingredients (1)
BENDAMUSTIN HYDROCHLORIDE MONOHYDRATE
Market Intelligence
- Owner Portfolio
- FERRON PAR PHARMACEUTICALS holds 190 BPOM registrations
- Manufacturer Scale
- FERRON PAR PHARMACEUTICALS - INDONESIA produces 186 registered products
- Registration Age
- Registered for 8 months
FDA Cross-Reference
via openFDA- Generic Name
- BENDAMUSTINE HYDROCHLORIDE
- Product Type
- HUMAN PRESCRIPTION DRUG
- Route of Administration
- INTRAVENOUS
Data sourced from the U.S. FDA drug label database (openFDA). May not exactly match this product variant.
Is this your product?
Claim it to manage registration, track renewals, and get expiry alerts.